These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3841537

  • 21. Chemical modification of steffimycin B.
    Wiley PF, Elrod DW, Harper DE.
    J Antibiot (Tokyo); 1988 Mar; 41(3):343-51. PubMed ID: 3366692
    [Abstract] [Full Text] [Related]

  • 22. Comparative redox activities of anthracyclines by microsomes from P388 cells and rat liver.
    Peters JH, Streeter DG, Johl JS, Gordon GR, Tracy M.
    Anticancer Res; 1987 Mar; 7(6):1189-91. PubMed ID: 3481682
    [Abstract] [Full Text] [Related]

  • 23. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M.
    Prog Clin Biol Res; 1986 Mar; 223():35-44. PubMed ID: 3468518
    [No Abstract] [Full Text] [Related]

  • 24. Synthesis and antitumor activity of 2'-bromo- and 2'-chloro-3'-acetoxy-3'-deaminodaunorubicin analogs.
    Horton D, Priebe W, Varela O.
    Carbohydr Res; 1985 Dec 01; 144(2):305-15. PubMed ID: 4092209
    [Abstract] [Full Text] [Related]

  • 25. Amino acid analogs of benanomicin A through desalaninebenanomicin A.
    Ikeda D, Nishizuka T, Huang SP, Kondo S, Takeuchi T.
    J Antibiot (Tokyo); 1992 Oct 01; 45(10):1645-52. PubMed ID: 1473992
    [Abstract] [Full Text] [Related]

  • 26. Nogalamycin analogs having improved antitumor activity.
    Wiley PF, Johnson JL, Houser DJ.
    J Antibiot (Tokyo); 1977 Jul 01; 30(7):628-9. PubMed ID: 893233
    [No Abstract] [Full Text] [Related]

  • 27. m-AMSA as a probe for transport phenomena associated with anthracycline resistance.
    Kessel D, Wheeler C.
    Biochem Pharmacol; 1984 Apr 01; 33(7):991-3. PubMed ID: 6585205
    [Abstract] [Full Text] [Related]

  • 28. New anthracycline derivatives from betaclamycin A.
    Yoshimoto A, Matsuzawa Y, Ishikura T, Sawa T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1984 Aug 01; 37(8):920-2. PubMed ID: 6480506
    [No Abstract] [Full Text] [Related]

  • 29. Antitumor activity of new morpholino anthracyclines.
    Komeshima N, Tsuruo T, Umezawa H.
    J Antibiot (Tokyo); 1988 Apr 01; 41(4):548-53. PubMed ID: 3163685
    [Abstract] [Full Text] [Related]

  • 30. Mode of action of calcium antagonists which alter anthracycline resistance.
    Kessel D, Wilberding C.
    Biochem Pharmacol; 1984 Apr 01; 33(7):1157-60. PubMed ID: 6585204
    [No Abstract] [Full Text] [Related]

  • 31. Chemical modification of anthracycline antibiotics. V. Synthesis of 2-hydroxyaclacinomycin A by chemical glycosidation.
    Tanaka H, Yoshioka T, Yoshimoto A, Shimauchi Y, Ishikura T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1983 May 01; 36(5):601-3. PubMed ID: 6874576
    [No Abstract] [Full Text] [Related]

  • 32. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
    Inaba M, Nagashima K, Sakurai Y, Fukui M, Yanagi Y.
    Gan; 1984 Dec 01; 75(12):1049-52. PubMed ID: 6597118
    [Abstract] [Full Text] [Related]

  • 33. New anthracycline antibiotics, auramycins and sulfurmycins. II. Isolation and characterization of 10 minor components (C approximately G).
    Hoshino T, Tazoe M, Nomura S, Fujiwara A.
    J Antibiot (Tokyo); 1982 Oct 01; 35(10):1271-9. PubMed ID: 7186414
    [Abstract] [Full Text] [Related]

  • 34. Adriamycin analogues. Preparation and antitumor evaluation of 7-O-(beta-D-glucosaminyl)daunomycinone and 7-O-(beta-D-glucosaminyl)adriamycinone and their N-trifluoroacetyl derivatives.
    Israel M, Murray RJ.
    J Med Chem; 1982 Jan 01; 25(1):24-8. PubMed ID: 7086817
    [Abstract] [Full Text] [Related]

  • 35. Chemical modification of ravidomycin and evaluation of biological activities of its derivatives.
    Rakhit S, Eng C, Baker H, Singh K.
    J Antibiot (Tokyo); 1983 Nov 01; 36(11):1490-4. PubMed ID: 6654759
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and cytotoxic activity of tetracenomycin D and of saintopin analogues.
    Martin P, Rodier S, Mondon M, Renoux B, Pfeiffer B, Renard P, Pierré A, Gesson JP.
    Bioorg Med Chem; 2002 Feb 01; 10(2):253-60. PubMed ID: 11741773
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and biological activity of 3'-deamino-3'-haloanthracyclines.
    Demetzos C, Skaltsounis AL, Michel S, Tillequin F, Koch M, Anstett M, Leonce S, Pierré A, Atassi G.
    Anticancer Drug Des; 1994 Apr 01; 9(2):129-37. PubMed ID: 8166928
    [Abstract] [Full Text] [Related]

  • 38. Synthesis of quinone derivatives of quinocarcin.
    Saito H, Sato A, Ashizawa T, Morimoto M, Hirata T.
    Chem Pharm Bull (Tokyo); 1990 Dec 01; 38(12):3202-10. PubMed ID: 2092928
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
    Kimura Y, Matsumoto T, Suzuki M, Terashima S.
    J Antibiot (Tokyo); 1985 Sep 01; 38(9):1277-9. PubMed ID: 4066509
    [No Abstract] [Full Text] [Related]

  • 40. Enantioselective synthesis of (+)-4-demethoxy-1,4-dimethyldaunomycinone.
    Kotha S, Stoodley RJ.
    Bioorg Med Chem; 2002 Mar 01; 10(3):621-4. PubMed ID: 11814850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.